• OPEN AN ACCOUNT
Indian Indices
Nifty
22,475.85 -172.35
(-0.76%)
Sensex
73,878.15 -732.96
( -0.98%)
Bank Nifty
48,923.55 -307.50
( -0.62%)
Nifty IT
32,908.40 -294.95
( -0.89%)
Global Indices
Nasdaq
16,156.33 315.37
(1.99%)
Dow Jones
38,675.68 450.02
(1.18%)
Hang Seng
18,475.92 268.79
(1.48%)
Nikkei 225
38,236.07 -37.98
(-0.10%)
Forex
USD-INR
83.43 -0.03
(-0.04%)
EUR-INR
89.37 0.26
(0.29%)
GBP-INR
104.48 0.21
(0.20%)
JPY-INR
0.54 0.01
(1.69%)

EQUITY - MARKET SCREENER

Prism Medico & Pharmacy Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512217
INE730E01016
25.0048318
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
146.88
14.25
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

As on: May 03, 2024 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
23.50 -0.45 7365 146.88
Stock Price Details
Open Price() 24.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 24.49
Today's Low () 23.21
52-Week High () 39.2
152-Week Low () 22.05
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 0.16
Book Value 25.0048318
Market Cap (.Cr) 14.25
Face Value 10
Market Lot 50
AGM Date Sep
Book Closure Date Sep
ISIN No. INE730E01016


News
Prism Medico & Pharmacy reports standalone net profit of Rs 0.19 crore in the December 2023 quarter
Prism Medico and Pharmacy to hold board meeting
Prism Medico & Pharmacy Ltd - Board Meeting Intimation for Intimation Of Board Meeting.
Prism Medico & Pharmacy Ltd - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Prism Medico & Pharmacy Ltd - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Prism Medico & Pharmacy Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Prism Medico & Pharmacy Ltd - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Prism Medico & Pharmacy Ltd - Compliance-57 (5) : intimation after the end of quarter
Prism Medico & Pharmacy reports standalone net loss of Rs 0.05 crore in the September 2023 quarter
Prism Medico & Pharmacy Ltd - Revision In Outcome Of Board Meeting Held On 08Th November 2023.
More
Corporate Details
Incoporation Year   : 2002
Chairman :
Bussiness Group :
Registered Office
Prism Medico & Pharmacy Ltd
D-118 Industrial Area,
Phase VII,
Mohali,
Punjab-160055
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:0172-5020762
Fax:N.A.
Fax:91-22-66317458
E-Mail : investorgrievancewmcl@gmail.com
URL : http://www.prismmedico.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi